10 ms·

This is a significant hit for a private company. If McK has 2,000 partners, that’s almost $300k per partner. (Yes - they are very well compensated, and this i

This is a significant hit for a private company. If McK has 2,000 partners, that’s almost $300k per partner. (Yes - they are very well compensated, and this is probably just a fraction of their pension plan)

onetimemanytime 6y ago
Well, considering the damage they caused this is nothing. They advised on /got and got paid for how to "turbocharge" opioid sales and that tuned out to be an illegal and immoral thing.
- samizdis 6y ago
  I'd be keen to see the specifics wrt advice given on how to "turbocharge" said sales. Reuters article doesn't give any examples/detail.
  - raesene9 6y ago
    Articles like https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-oxycontin-opioids.html https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-... have some details. A quote from that shows some details :- " In a 2017 presentation, according to the records, which were filed in court on behalf of multiple state attorneys general, McKinsey laid out several options to shore up sales. One was to give Purdue’s distributors a rebate for every OxyContin overdose attributable to pills they sold. The presentation estimated how many customers of companies including CVS and Anthem might overdose. It projected that in 2019, for example, 2,484 CVS customers would either have an overdose or develop an opioid use disorder. A rebate of $14,810 per “event” meant that Purdue would pay CVS $36.8 million that year. "
    - samizdis 6y ago
      Many thanks; an informative read. FWIW I've just come across a related piece in Jacobin from December 2020: https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opioid-epidemic-purdue-pharma https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opio...
    - sjg007 6y ago
      I mean that logic is just sick and heartless.
    - a3n 6y ago
      So, they recommended paying distributors to kill people. Because, in addition to the profit distributors would make by merely being in business, they would make even more money for each related death.
  - rn086 6y ago
    an article I saw said they targeted outreach at doctors who were more likely to write Rxs edit: beaten w/ the article
  - alex_anglin 6y ago
    Many details have been published in the media. For instance: "Documents filed in U.S. courts last year outlined how McKinsey discussed ways for Purdue to “turbocharge” sales of its drug OxyContin, including paying Purdue’s distributors a rebate for every OxyContin overdose attributable to pills they sold." source: https://www.theglobeandmail.com/politics/article-mckinsey-is-open-to-settlement-regarding-opioid-work-in-the-us-and/ https://www.theglobeandmail.com/politics/article-mckinsey-is...
Pasorrijer 6y ago
It's peanuts. This likely will be covered by some form of insurance, and very little will change.

onetimemanytime 6y ago

Well, considering the damage they caused this is nothing. They advised on /got and got paid for how to "turbocharge" opioid sales and that tuned out to be an illegal and immoral thing.

samizdis 6y ago
I'd be keen to see the specifics wrt advice given on how to "turbocharge" said sales. Reuters article doesn't give any examples/detail.
- raesene9 6y ago
  Articles like https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-oxycontin-opioids.html https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-... have some details. A quote from that shows some details :- " In a 2017 presentation, according to the records, which were filed in court on behalf of multiple state attorneys general, McKinsey laid out several options to shore up sales. One was to give Purdue’s distributors a rebate for every OxyContin overdose attributable to pills they sold. The presentation estimated how many customers of companies including CVS and Anthem might overdose. It projected that in 2019, for example, 2,484 CVS customers would either have an overdose or develop an opioid use disorder. A rebate of $14,810 per “event” meant that Purdue would pay CVS $36.8 million that year. "
  - samizdis 6y ago
    Many thanks; an informative read. FWIW I've just come across a related piece in Jacobin from December 2020: https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opioid-epidemic-purdue-pharma https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opio...
  - sjg007 6y ago
    I mean that logic is just sick and heartless.
  - a3n 6y ago
    So, they recommended paying distributors to kill people. Because, in addition to the profit distributors would make by merely being in business, they would make even more money for each related death.
- rn086 6y ago
  an article I saw said they targeted outreach at doctors who were more likely to write Rxs edit: beaten w/ the article
- alex_anglin 6y ago
  Many details have been published in the media. For instance: "Documents filed in U.S. courts last year outlined how McKinsey discussed ways for Purdue to “turbocharge” sales of its drug OxyContin, including paying Purdue’s distributors a rebate for every OxyContin overdose attributable to pills they sold." source: https://www.theglobeandmail.com/politics/article-mckinsey-is-open-to-settlement-regarding-opioid-work-in-the-us-and/ https://www.theglobeandmail.com/politics/article-mckinsey-is...

Pasorrijer 6y ago

It's peanuts. This likely will be covered by some form of insurance, and very little will change.